Mirion Technologies (NYSE:MIR – Get Free Report) issued an update on its FY24 earnings guidance on Tuesday morning. The company provided EPS guidance of $0.37-$0.42 for the period, compared to the consensus EPS estimate of $0.39. The company issued revenue guidance of $840.9-$856.9 million, compared to the consensus revenue estimate of $848.25 million. Mirion Technologies also updated its FY 2024 guidance to 0.370-0.420 EPS.
Mirion Technologies Price Performance
NYSE:MIR traded down $0.16 during trading hours on Tuesday, reaching $10.86. 2,312,267 shares of the company were exchanged, compared to its average volume of 1,167,114. The company has a current ratio of 2.03, a quick ratio of 1.48 and a debt-to-equity ratio of 0.44. The firm has a market cap of $2.46 billion, a PE ratio of -21.72 and a beta of 0.81. Mirion Technologies has a twelve month low of $6.70 and a twelve month high of $11.49. The stock’s 50-day moving average is $10.59 and its 200-day moving average is $9.63.
Mirion Technologies (NYSE:MIR – Get Free Report) last issued its quarterly earnings results on Tuesday, February 13th. The company reported $0.12 earnings per share for the quarter. Mirion Technologies had a negative net margin of 12.01% and a positive return on equity of 3.09%. The firm had revenue of $230.40 million for the quarter.
Wall Street Analyst Weigh In
View Our Latest Research Report on Mirion Technologies
Insider Buying and Selling at Mirion Technologies
In related news, CFO Brian Schopfer sold 90,910 shares of the business’s stock in a transaction dated Wednesday, March 20th. The shares were sold at an average price of $11.00, for a total value of $1,000,010.00. Following the sale, the chief financial officer now directly owns 211,167 shares in the company, valued at approximately $2,322,837. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 2.57% of the company’s stock.
About Mirion Technologies
Mirion Technologies, Inc provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies.
Featured Stories
- Five stocks we like better than Mirion Technologies
- Consumer Discretionary Stocks Explained
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- What is the Hang Seng index?
- Hilton Demonstrates Asset Light is Right for Investors
- Stock Sentiment Analysis: How it Works
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for Mirion Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mirion Technologies and related companies with MarketBeat.com's FREE daily email newsletter.